Abuja Heart Study: Prospective Epidemiological Investigation of Cardiovascular Diseases (AHS)

September 25, 2013 updated by: uchenna onyeachom, Healthsystem Plus

Abuja Heart Study (AHS) is a Multi-site Prospective Epidemiological Investigation of Cardiovascular Disease (CVD) .

This is a multi-site prospective epidemiological investigation of cardiovascular disease (CVD) among Abuja residents from the rural and metropolitan area.

Study Overview

Status

Unknown

Conditions

Detailed Description

Sub-Saharan Africa continues to fight the battle of infectious diseases such as HIV/AIDS, Tuberculosis and Malaria. But given all the international efforts geared to curing and containing these diseases, and with progress made in various countries, Sub-Saharan Africa is now heading into another type of epidemic, cardiovascular disease (CVD). Predicted statistics have shown that cardiovascular diseases will become the leading cause of death in developing countries within the next 10 to 15 years, however relatively few population-based studies have examined CVD in Africa .

Although control of communicable ,childhood ,and maternal diseases has benefited from an international efforts on clinical care, policy and implementation,such large scale effort are lacking for CVD and have left both policymakers and individuals with decisions on health issues without adequate information.

Prior to the commencement of the study,series of community meetings and focus groups discussions will be held to identify ways to enhance participation. An extensive examination will include a series of questionnaires dealing with lifestyle habits, medical history, social and cultural factors, physical assessments which include height, weight,central blood pressure assessment of arterial stiffness and autonomic function and laboratory measurements for cholesterol, other lipids, glucose ,c-reactive protein among others.

Study Type

Observational

Enrollment (Anticipated)

10000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Nigeria
      • Abuja, Nigeria
        • Recruiting
        • Nigerian Defense Medical Center
      • Federal Capital Territory, Nigeria
        • Recruiting
        • Gwagwalada Specialist Hospital
    • Federal Capital Territory
      • Abuja, Federal Capital Territory, Nigeria
        • Recruiting
        • National Hospital Abuja
      • Abuja, Federal Capital Territory, Nigeria
        • Recruiting
        • State House Medical Center
      • Bwari, Federal Capital Territory, Nigeria
        • Recruiting
        • Bwari General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 64 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Abuja residents from the rural and metropolitan area.

Description

Inclusion Criteria:

  • Some history of cardiovascular disease,PLWHA
  • Patients have to agree to participate by signing a consent
  • 18 years and older

Exclusion Criteria:

  • Stroke

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
I

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
determine the roles of sociocultural factors, such as poverty,gender, literacy, stress in the development of CVD and associated risk factors
Time Frame: 5
5

Secondary Outcome Measures

Outcome Measure
Time Frame
familial or hereditary factors
Time Frame: 10
10

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Healthsystem Plus

Collaborators

Baim Institute for Clinical Research
Federal Ministry of Health, Nigeria
Akaza Research
Byrne Healthcare

Investigators

  • Principal Investigator: Uchenna N Onyeachom, Healthsystem Plus
  • Principal Investigator: Ngozi A Njepuome, Abuja Heart Study
  • Study Chair: Chimele Abengowe, National Hospital, Abuja

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2009

Primary Completion (Anticipated)

November 1, 2014

Study Completion (Anticipated)

November 1, 2016

Study Registration Dates

First Submitted

February 25, 2008

First Submitted That Met QC Criteria

March 5, 2008

First Posted (Estimate)

March 6, 2008

Study Record Updates

Last Update Posted (Estimate)

September 26, 2013

Last Update Submitted That Met QC Criteria

September 25, 2013

Last Verified

August 1, 2012

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HIFA-001

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe